Gensia Pharmaceuticals, Inc. – Trademark Portfolio

Entity Type: 03

Gensia Pharmaceuticals, Inc. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. The owner is based in San Diego, CA.

11025 Roselle Street

San Diego, CA 92121

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

GENSIA
GENSIA
Cancelled 1992
GENESA
GENESA
Cancelled 1991
GENESA
GENESA
Cancelled 1991
GENLYTE
GENLYTE
Cancelled 1991
ARASINE
ARASINE
Abandoned 1990
AICASINE
AICASINE
Abandoned 1990

Trademark Classifications

Gensia Pharmaceuticals, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

40
Treatment & Processing (2 filings)

Treatment of materials

Frequently Asked Questions

How many trademarks does Gensia Pharmaceuticals, Inc. have?

Gensia Pharmaceuticals, Inc. has 10 U.S. trademarks filed with the USPTO.

What trademark classes does Gensia Pharmaceuticals, Inc. file in?

Gensia Pharmaceuticals, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Gensia Pharmaceuticals, Inc.'s trademark registration success rate?

Gensia Pharmaceuticals, Inc. has a 0% trademark registration rate, with 0 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.